Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation
Year: 2025
Type: article
Language: en
Topic: HIV Research and Treatment
Authors and affiliations:
raw_author_name: Christian Gaebler
raw_affiliation_strings: Berlin Institute of Health, Berlin, Germany. christian.gaebler@charite.de
Laboratory of Translational Immunology of Viral Infections, Department of Infectious Diseases and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. christian.gaebler@charite.de
Berlin Institute of Health, Berlin, Germany
Laboratory of Translational Immunology of Viral Infections, Department of Infectious Diseases and Critical Care Medicine, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: Samad Kor
raw_affiliation_strings: Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
National Center for Tumor Diseases (NCT), Partner Site, Berlin, Germany
Department of Hematology, Oncology and Tumor Immunology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: Kristina Allers
raw_affiliation_strings: Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: Michela Perotti
raw_affiliation_strings: Berlin Institute of Health, Berlin, Germany
Laboratory of Translational Immunology of Viral Infections, Department of Infectious Diseases and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Laboratory of Translational Immunology of Viral Infections, Department of Infectious Diseases and Critical Care Medicine, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: David Mwangi
raw_affiliation_strings: Laboratory MVZ MIB-Medical Center for Infectious Diseases, Berlin, Germany
Laboratory MVZ MIB AG - Medical Center for Infectious Diseases, Berlin, Germany
raw_author_name: Karolin Meixenberger
raw_affiliation_strings: Division of Sexually Transmitted Bacterial Pathogens (STI) and HIV, Robert Koch Institute, Berlin, Germany
Division of Sexually transmitted bacterial Pathogens (STI) and HIV, Robert Koch Institute, Berlin, Germany
raw_author_name: Kirsten Hanke
raw_affiliation_strings: Division of Sexually Transmitted Bacterial Pathogens (STI) and HIV, Robert Koch Institute, Berlin, Germany
Division of Sexually transmitted bacterial Pathogens (STI) and HIV, Robert Koch Institute, Berlin, Germany
raw_author_name: Timo Trenkner
raw_affiliation_strings: First Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
raw_author_name: Tom Kraus
raw_affiliation_strings: First Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
raw_author_name: Yeqin Sha
raw_affiliation_strings: Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Department of Hematology, Oncology and Tumor Immunology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: Carmen Arentowicz
raw_affiliation_strings: Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany
Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, and German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany
raw_author_name: Stanley Odidika
raw_affiliation_strings: Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany
Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, and German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany
raw_author_name: Nikolai Grahn
raw_affiliation_strings: Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany
Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, and German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany
raw_author_name: Rachel Scheck
raw_affiliation_strings: Berlin Institute of Health, Berlin, Germany
Laboratory of Translational Immunology of Viral Infections, Department of Infectious Diseases and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Laboratory of Translational Immunology of Viral Infections, Department of Infectious Diseases and Critical Care Medicine, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: Naomi Perkins
raw_affiliation_strings: Berlin Institute of Health, Berlin, Germany
Laboratory of Translational Immunology of Viral Infections, Department of Infectious Diseases and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Laboratory of Translational Immunology of Viral Infections, Department of Infectious Diseases and Critical Care Medicine, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: Marion Pardons
raw_affiliation_strings: Berlin Institute of Health, Berlin, Germany
Laboratory of Translational Immunology of Viral Infections, Department of Infectious Diseases and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: Vanessa Igbokwe
raw_affiliation_strings: Berlin Institute of Health, Berlin, Germany
Laboratory of Translational Immunology of Viral Infections, Department of Infectious Diseases and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: Victor Corman
raw_affiliation_strings: Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Labor Berlin-Charité Vivantes, Berlin, Germany
Labor Berlin - Charité Vivantes GmbH, Berlin, Germany
Institute of Virology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: Thomas Burmeister
raw_affiliation_strings: Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
National Center for Tumor Diseases (NCT), Partner Site, Berlin, Germany
Department of Hematology, Oncology and Tumor Immunology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: Olga Blau
raw_affiliation_strings: Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
National Center for Tumor Diseases (NCT), Partner Site, Berlin, Germany
Department of Hematology, Oncology and Tumor Immunology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: Gülüstan Sürücü
raw_affiliation_strings: Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Institute of Transfusion Medicine, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: Axel Pruß
raw_affiliation_strings: Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Institute of Transfusion Medicine, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: Christian G. Schneider
raw_affiliation_strings: Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
National Center for Tumor Diseases (NCT), Partner Site, Berlin, Germany
Department of Hematology, Oncology and Tumor Immunology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: Gerd Klausen
raw_affiliation_strings: SPP-Mitte, Specialist Practice for Infection Medicine at Oranienburger Tor, Berlin, Germany
raw_author_name: Jürgen Sauter
raw_affiliation_strings: DKMS Group, Tübingen, Germany
raw_author_name: Florian Klein
raw_affiliation_strings: German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany
Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
raw_author_name: Leif E. Sander
raw_affiliation_strings: Berlin Institute of Health, Berlin, Germany
Department of Infectious Diseases and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Department of Infectious Diseases and Critical Care Medicine, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: Jörg Hofmann
raw_affiliation_strings: Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Labor Berlin-Charité Vivantes, Berlin, Germany
Institute of Virology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Labor Berlin - Charité Vivantes GmbH, Berlin, Germany
raw_author_name: Lam Vuong
raw_affiliation_strings: Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
National Center for Tumor Diseases (NCT), Partner Site, Berlin, Germany
Department of Hematology, Oncology and Tumor Immunology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: Lars Bullinger
raw_affiliation_strings: Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
National Center for Tumor Diseases (NCT), Partner Site, Berlin, Germany
Department of Hematology, Oncology and Tumor Immunology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: Livius Penter
raw_affiliation_strings: Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Department of Hematology, Oncology and Tumor Immunology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: Henning Gruell
raw_affiliation_strings: Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
raw_author_name: Daniel B. Reeves
raw_affiliation_strings: Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
raw_author_name: Philipp Schommers
raw_affiliation_strings: Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany
Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, and German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany
raw_author_name: Angelique Hoelzemer
raw_affiliation_strings: First Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Institute for Infection and Vaccine Development (IIRVD), University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Leibniz Institute of Virology, Hamburg, Germany
raw_author_name: Martin Obermeier
raw_affiliation_strings: Laboratory MVZ MIB-Medical Center for Infectious Diseases, Berlin, Germany
Laboratory MVZ MIB AG - Medical Center for Infectious Diseases, Berlin, Germany
raw_author_name: Igor W. Blau
raw_affiliation_strings: Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
National Center for Tumor Diseases (NCT), Partner Site, Berlin, Germany
Department of Hematology, Oncology and Tumor Immunology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: Thomas Schneider
raw_affiliation_strings: Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
raw_author_name: Olaf Penack
raw_affiliation_strings: Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. olaf.penack@charite.de
National Center for Tumor Diseases (NCT), Partner Site, Berlin, Germany. olaf.penack@charite.de
National Center for Tumor Diseases (NCT), Partner Site, Berlin, Germany
Department of Hematology, Oncology and Tumor Immunology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany